rs121964988
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000108.5(DLD):c.1463C>T(p.Pro488Leu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000108.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLD | NM_000108.5 | c.1463C>T | p.Pro488Leu | missense_variant, splice_region_variant | 13/14 | ENST00000205402.10 | NP_000099.2 | |
DLD | NM_001289751.1 | c.1394C>T | p.Pro465Leu | missense_variant, splice_region_variant | 12/13 | NP_001276680.1 | ||
DLD | NM_001289752.1 | c.1319C>T | p.Pro440Leu | missense_variant, splice_region_variant | 12/13 | NP_001276681.1 | ||
DLD | NM_001289750.1 | c.1166C>T | p.Pro389Leu | missense_variant, splice_region_variant | 11/12 | NP_001276679.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLD | ENST00000205402.10 | c.1463C>T | p.Pro488Leu | missense_variant, splice_region_variant | 13/14 | 1 | NM_000108.5 | ENSP00000205402 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251298Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135802
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1461112Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726910
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298
ClinVar
Submissions by phenotype
Pyruvate dehydrogenase E3 deficiency Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 12, 2024 | Variant summary: DLD c.1463C>T (p.Pro488Leu) results in a non-conservative amino acid change located in the Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain (IPR004099) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.6e-05 in 251298 control chromosomes. c.1463C>T has been reported in the literature in a compound heterozygous individual affected with Dihydrolipoamide Dehydrogenase Deficiency (MSUD Type 3) whose cells had 6% of the E3 activity of control cells, but normal citrate synthase activity (Liu_1993). This report suggests the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The purified protein results in <10% dihydrolipoamide dehydrogenase activity compared to the WT (e.g. Ambrus_2011). The following publications have been ascertained in the context of this evaluation (PMID: 21558426, 16770810, 8506365, 23290025, 9934985). ClinVar contains an entry for this variant (Variation ID: 11965). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1993 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at